-
1
-
-
41349099104
-
Cancer statistics, 2008
-
18287387 10.3322/CA.2007.0010
-
Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin, 2008,58(2):71-96
-
(2008)
CA Cancer J Clin
, vol.58
, Issue.2
, pp. 71-96
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
-
2
-
-
0034810996
-
Cloning, characterization, and expression of human LIG1
-
11414704 10.1006/bbrc.2001.5092 1:CAS:528:DC%2BD3MXksVKjtr8%3D
-
Nilsson J, Vallbo C, Guo D, et al. Cloning, characterization, and expression of human LIG1. Biochem Biophys Res Commun, 2001,284(5):1155-1161
-
(2001)
Biochem Biophys Res Commun
, vol.284
, Issue.5
, pp. 1155-1161
-
-
Nilsson, J.1
Vallbo, C.2
Guo, D.3
-
3
-
-
2442526679
-
Characterization and tissue-specific expression of human LRIG2
-
15145052 10.1016/j.gene.2004.02.002 1:CAS:528:DC%2BD2cXjvFOku7o%3D
-
Holmlund C, Nilsson J, Guo D, et al. Characterization and tissue-specific expression of human LRIG2. Gene, 2004,332(12):35-43
-
(2004)
Gene
, vol.332
, Issue.12
, pp. 35-43
-
-
Holmlund, C.1
Nilsson, J.2
Guo, D.3
-
4
-
-
2942534392
-
The LRIG gene family has three vertebrate paralogs widely expressed in human and mouse tissues and a homolog in Ascidiacea
-
15203213 10.1016/j.ygeno.2004.01.013 1:CAS:528:DC%2BD2cXkvFyls70%3D
-
Guo D, Holmlund C, Henriksson R, et al. The LRIG gene family has three vertebrate paralogs widely expressed in human and mouse tissues and a homolog in Ascidiacea. Genomics, 2004,84(1):157-165
-
(2004)
Genomics
, vol.84
, Issue.1
, pp. 157-165
-
-
Guo, D.1
Holmlund, C.2
Henriksson, R.3
-
5
-
-
8744267487
-
The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases
-
10.1074/jbc.M409703200 1:CAS:528:DC%2BD2cXptFejsLk%3D 050-47 056
-
Laederich MB, Funes-Duran M, Yen L, et al. The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases. J Biol Chem, 2004,279(45):47 050-47 056
-
(2004)
J Biol Chem
, vol.279
, Issue.45
, pp. 47
-
-
Laederich, M.B.1
Funes-Duran, M.2
Yen, L.3
-
6
-
-
20844462896
-
LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation
-
15282549 10.1038/sj.emboj.7600342 1:CAS:528:DC%2BD2cXmslWhtL0%3D
-
Gur G, Rubin C, Katz M, et al. LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation. EMBO J, 2004,23(16): 3270-3281
-
(2004)
EMBO J
, vol.23
, Issue.16
, pp. 3270-3281
-
-
Gur, G.1
Rubin, C.2
Katz, M.3
-
7
-
-
33847181657
-
LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy
-
17178829 10.1128/MCB.00757-06 1:CAS:528:DC%2BD2sXit1Wgu7w%3D
-
Shattuck DL, Miller JK, Laederich M, et al. LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy. Mol Cell Biol, 2007,27(5): 1934-1946
-
(2007)
Mol Cell Biol
, vol.27
, Issue.5
, pp. 1934-1946
-
-
Shattuck, D.L.1
Miller, J.K.2
Laederich, M.3
-
8
-
-
0029800810
-
Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets
-
8912848 1:CAS:528:DyaK28XntFOnu7s%3D
-
Reifenberger G, Ichimura K, Reifenberger J, et al. Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets. Cancer Res, 1996,56(22): 5141-5145
-
(1996)
Cancer Res
, vol.56
, Issue.22
, pp. 5141-5145
-
-
Reifenberger, G.1
Ichimura, K.2
Reifenberger, J.3
-
9
-
-
0036352654
-
Is LRIG1 a tumour suppressor gene at chromosome 3p14.3
-
12234026 10.1080/028418602760169398 1:CAS:528:DC%2BD3sXitV2g
-
Hedman H, Nilsson J, Guo D, et al. Is LRIG1 a tumour suppressor gene at chromosome 3p14.3? Acta Oncol, 2002,41(4):352-354
-
(2002)
Acta Oncol
, vol.41
, Issue.4
, pp. 352-354
-
-
Hedman, H.1
Nilsson, J.2
Guo, D.3
-
10
-
-
63449093719
-
Inhibition of LRIG3 gene expression via RNA interference modulates the proliferation, cell cycle, cell apoptosis, adhesion and invasion of glioblastoma cell (GL15)
-
19200647 10.1016/j.canlet.2009.01.001 1:CAS:528:DC%2BD1MXktFajsr8%3D
-
Cai M, Han L, Chen R, et al. Inhibition of LRIG3 gene expression via RNA interference modulates the proliferation, cell cycle, cell apoptosis, adhesion and invasion of glioblastoma cell (GL15). Cancer Lett, 2009,278(1): 104-112
-
(2009)
Cancer Lett
, vol.278
, Issue.1
, pp. 104-112
-
-
Cai, M.1
Han, L.2
Chen, R.3
-
11
-
-
0037207873
-
Laminin gamma2-chain fragment in the circulation: A prognostic indicator of epithelial tumor invasion
-
12517801 1:CAS:528:DC%2BD3sXjvFKnsA%3D%3D
-
Katayama M, Sanzen N, Funakoshi A, et al. Laminin gamma2-chain fragment in the circulation: a prognostic indicator of epithelial tumor invasion. Cancer Res, 2003,63(1):222-229
-
(2003)
Cancer Res
, vol.63
, Issue.1
, pp. 222-229
-
-
Katayama, M.1
Sanzen, N.2
Funakoshi, A.3
-
12
-
-
0037325180
-
Breast cancer stromal myxoid changes are associated with tumor invasion and metastasis: A central role for hyaluronan
-
12591961 10.1097/01.MP.0000051582.75890.2D
-
Wernicke M, Pineiro LC, Caramutti D, et al. Breast cancer stromal myxoid changes are associated with tumor invasion and metastasis: a central role for hyaluronan. Mod Pathol, 2003,16(2):99-107
-
(2003)
Mod Pathol
, vol.16
, Issue.2
, pp. 99-107
-
-
Wernicke, M.1
Pineiro, L.C.2
Caramutti, D.3
-
13
-
-
0037621786
-
Heparanase and tumor invasion patterns in human oral squamous cell carcinoma xenografts
-
12824922 10.1111/j.1349-7006.2003.tb01433.x 1:CAS:528: DC%2BD3sXktVCqsL0%3D
-
Kurokawa H, Katsube K, Podyma KA, et al. Heparanase and tumor invasion patterns in human oral squamous cell carcinoma xenografts. Cancer Sci, 2003,94(3):277-285
-
(2003)
Cancer Sci
, vol.94
, Issue.3
, pp. 277-285
-
-
Kurokawa, H.1
Katsube, K.2
Podyma, K.A.3
-
14
-
-
0034773992
-
The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities
-
11597398 10.1016/S0959-8049(01)00230-1 1:CAS:528:DC%2BD3MXntlOku78%3D
-
Yarden Y. The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. Eur J Cancer, 2001,37(Suppl 4):S3-8
-
(2001)
Eur J Cancer
, vol.37
, Issue.SUPPL.4
, pp. 3-8
-
-
Yarden, Y.1
-
15
-
-
0034954124
-
The type III epidermal growth factor receptor mutation. Biological significance and potential target for anti-cancer therapy
-
11484948 10.1023/A:1011177318162 1:STN:280:DC%2BD38%2FislSktw%3D%3D
-
Pedersen MW, Meltorn M, Damstrup L, et al. The type III epidermal growth factor receptor mutation. Biological significance and potential target for anti-cancer therapy. Ann Oncol, 2001,12(6):745-760
-
(2001)
Ann Oncol
, vol.12
, Issue.6
, pp. 745-760
-
-
Pedersen, M.W.1
Meltorn, M.2
Damstrup, L.3
-
16
-
-
0027948163
-
Epidermal growth factor receptor gene expression and binding capacity in renal cell carcinoma, in relation to tumor stage, grade and DNA ploidy
-
7879316 10.1007/BF00297200 1:CAS:528:DyaK2MXjsVWqsr0%3D
-
Ljungberg B, Gafvels M, Damber JE. Epidermal growth factor receptor gene expression and binding capacity in renal cell carcinoma, in relation to tumor stage, grade and DNA ploidy. Urol Res, 1994,22(5):305-308
-
(1994)
Urol Res
, vol.22
, Issue.5
, pp. 305-308
-
-
Ljungberg, B.1
Gafvels, M.2
Damber, J.E.3
-
17
-
-
68949144565
-
Upregulation of LRIG1 suppresses malignant glioma cell growth by attenuating EGFR activity
-
19300910 10.1007/s11060-009-9836-1 1:CAS:528:DC%2BD1MXps1CjtL0%3D
-
Ye F, Gao Q, Xu T, et al. Upregulation of LRIG1 suppresses malignant glioma cell growth by attenuating EGFR activity. J Neurooncol, 2009,94(2):183-194
-
(2009)
J Neurooncol
, vol.94
, Issue.2
, pp. 183-194
-
-
Ye, F.1
Gao, Q.2
Xu, T.3
-
18
-
-
79958204380
-
Suppression of bladder cancer cell tumorigenicity in an athymic mouse model by adenoviral vector-mediated transfer of LRIG1
-
21567105
-
Li F, Ye ZQ, Guo DS, et al. Suppression of bladder cancer cell tumorigenicity in an athymic mouse model by adenoviral vector-mediated transfer of LRIG1. Oncol Rep, 2011,26(2):439-446
-
(2011)
Oncol Rep
, vol.26
, Issue.2
, pp. 439-446
-
-
Li, F.1
Ye, Z.Q.2
Guo, D.S.3
|